135 filings
Page 3 of 7
8-K
qahg4341sk5wmkajy
24 Sep 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
12:00am
8-K
571bd 2e4zytzmx
23 Sep 21
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
7:54am
8-K
arevzk61 4t8bpn
30 Aug 21
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
7:15am
8-K
ky1y31 iv
20 May 21
Departure of Directors or Certain Officers
4:33pm
8-K
gs36o 16f4tffr7pmfv
11 May 21
Departure of Directors or Certain Officers
7:30am
8-K
4sa327w
4 May 21
Catalent, Inc. Reports Third Quarter Fiscal 2021 Results
7:07am
8-K
jxgqloesva
22 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
5gl r8zp06074wvm
10 Feb 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
5:29pm
8-K
6okq8fvipjmzo7kv
10 Feb 21
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
7:50am
8-K
no9txgfabnx06d e8lr6
2 Feb 21
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
7:21am
8-K
txy qb7yshb
3 Nov 20
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
7:13am
8-K
tut0ofnhal6s uvb
31 Aug 20
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
7:06am
8-K
4tga570cz2oahe63roj
30 Jul 20
Results of Operations and Financial Condition
8:22am
8-K
skxpae2wy
15 Jun 20
Entry into a Material Definitive Agreement
4:20pm
8-K
60p8rywy wmu8
11 Jun 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
8:52am
8-K
n63h4an2774uxn9
10 Jun 20
Catalent, Inc. Announces Public Offering of Common Stock
4:19pm
8-K
a1qtztv0sbmj2wr1ug
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
potmu 3e95g
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
x0zzsm2a09mxc ide7n
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
1t0vqw4kk
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm